GlaxoSmithKline PLCGSK:LSE

0.00 / 0.00%
Latest price in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of May 26 2016 13:16 BST.


As of last trade GlaxoSmithKline PLC (GSK:LSE) traded at 1,454, 5.10 % below its 52-week high of 1,532.1, set on Apr 13, 2016.

52-week range
Sep 29 2015
Apr 13 2016
Markit short selling activity
Day high1,458.5
Day low1,447.5
Previous close1,454
Average volume6.75m
Shares outstanding4.87bn
Free float4.83bn
P/E (TTM)115.23
Market cap70.37bn GBP
EPS (TTM)0.1254 GBP
Annual div (IAD)80.00 GBX
Annual div yield (IAD)5.54%
Div ex-dateMay 12 2016
Div pay-dateJul 14 2016
Data delayed at least 15 minutes, as of May 26 2016 13:16 BST.
Last IC View
The last IC recommendation on GlaxoSmithKline PLC shares was Sell at 1,444 on 05 May 2016
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
GlaxoSmithKline PLC+3.30 %-0.31 %+9.68 %+3.13 %+12.06 %
FTSE 100 IDX+3.47 %-0.34 %-2.03 %-9.87 %+6.50 %
GB/HEALTH CARE+4.14 %+0.60 %-2.55 %-6.45 %+23.00 %
GB/PHARMACEUTICALS+4.15 %+0.54 %-2.86 %-7.00 %+21.65 %
Data delayed at least 15 minutes, as of May 26 2016 13:16 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.